naion glp-1 Breaking Med Andrew Lee, MD | NAION
Description
All authors approved the final manuscript
[cited 2025 Jun 8]
These effects are observed across substances and models, including operant self-administration, CPP, reinstatement paradigms, and neurochemical readouts
Effects of GLP-1 and incretin-based therapies on gastrointestinal motor function
PMCID: PMC11397063.
